eli lilly hypoglycemia treatment wins fda approval food drug administration approved eli lilly co treatment severe hypoglycemia health regulator said wednesday reuters food drug administration approved eli lilly co treatment severe hypoglycemia health regulator said wednesday hypoglycemia condition blood sugar falls dangerously low levels severe hypoglycemia typically occurs people diabetes using insulin treatment fda said noted therapy baqsimi approved treat severe form condition patients diabetes aged older baqsimi powder administered nose glucagon therapy approved emergency treatment condition using injection agency said new way administer glucagon may simplify process critical episode said janet woodcock director fda center drug evaluation research fda said injectable glucagon approved use united states several decades